Drug Shortage Report for TEVA-ESCITALOPRAM
| Report ID | 122717 |
| Drug Identification Number | 02318202 |
| Brand name | TEVA-ESCITALOPRAM |
| Common or Proper name | TEVA-ESCITALOPRAM 20MG TABLETS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ESCITALOPRAM |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N06AB |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-08-20 |
| Estimated end date | 2020-11-30 |
| Actual end date | 2020-09-23 |
| Shortage status | Resolved |
| Updated date | 2020-09-24 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.